c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism-Reference-Cited by-同舟云学术

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Published:2009-02-15 Issue:7239 Volume:458 Page:762-765
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Gao Ping,Tchernyshyov Irina,Chang Tsung-Cheng,Lee Yun-Sil,Kita Kayoko,Ochi Takafumi,Zeller Karen I.,De Marzo Angelo M.,Van Eyk Jennifer E.,Mendell Joshua T.,Dang Chi V.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature07823.pdf

Reference30 articles.

1. Deberardinis, R. J., Sayed, N., Ditsworth, D. & Thompson, C. B. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18, 54–61 (2008)

2. Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 13, 472–482 (2008)

3. DeBerardinis, R. J. et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA 104, 19345–19350 (2007)

4. Reitzer, L. J., Wice, B. M. & Kennell, D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254, 2669–2676 (1979)

5. Gallagher, F. A., Kettunen, M. I., Day, S. E., Lerche, M. & Brindle, K. M. 13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C-labeled glutamine. Magn. Reson. Med. 60, 253–257 (2008)

Cited by 1797 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of the Otubains subfamily in hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-10

2. MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy;Translational Psychiatry;2024-09-10

3. Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer;Journal of Cellular Physiology;2024-09-08

4. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment;Biomarker Research;2024-09-03

5. Combining the novel FLT3 and MERTK dual inhibitor MRX-2843 with venetoclax results in promising antileukemic activity against FLT3-ITD AML;Leukemia Research;2024-09